Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia.
about
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningNox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke.Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.Nitroxyl donors retain their depressor effects in hypertension.The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.Nitroxyl (HNO) for treatment of acute heart failure.Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.Oxidant sensor in the cGMP-binding pocket of PKGIα regulates nitroxyl-mediated kinase activity.Inhibition of platelet aggregation ex vivo is repressed in apolipoprotein E deficient mice.Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.
P2860
Q26825733-4313CD8F-FCFF-4453-8DEB-3652E40F40ADQ34099222-5FC318A5-6E83-4000-892E-96B7090DBB2DQ34892722-2D24AF9D-4D13-438F-9C88-E6B8C9150B55Q36573243-F8618815-9A7A-4248-91F6-39D12DE7FFD3Q37142767-E979795D-04EC-4333-B1A9-2FEC9E4E228EQ37665613-254A4967-0DB2-4C67-B112-05296D24357FQ38224809-2315C472-0D54-4739-BA57-F43CC1AA6B30Q38827338-A6467AFD-0F31-495F-9139-5680A2E75725Q41565976-CCEEC028-FC9D-46F3-8B59-09968264A4C9Q42512335-0C08FB5B-922D-4AC4-83FF-2A0AFC543530Q46434234-BACFC2B5-863D-46AE-B3FD-E80E82B27AC7
P2860
Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@en
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@nl
type
label
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@en
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@nl
prefLabel
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@en
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@nl
P2093
P2860
P1476
Vasorelaxant and antiaggregato ...... ained in hypercholesterolemia.
@en
P2093
Alyson A Miller
Barbara K Kemp-Harper
Christopher G Sobey
Janahan Dharmarajah
Michelle L Bullen
P2860
P304
P356
10.1152/AJPHEART.00489.2011
P577
2011-07-29T00:00:00Z